| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 04/21/2005 | US20050084876 Flip genes and flip proteins |
| 04/21/2005 | US20050084853 Nucleotide sequences coding actin binding protein for use as tool in identifying modulator for prevention and treatment of fungal infection; fungicides |
| 04/21/2005 | US20050084850 Stromal cell protein for use as tool in stimulating blood production in patients undergoing chemotherapy |
| 04/21/2005 | US20050084839 Method for selecting oocytes by using a response to LPA stimulation |
| 04/21/2005 | US20050084512 Non-biodegradable crosslinked polyvinylalcohol derivatized with alkylamino groups which forms a sponge-like scaffold with a plurality of interconnected pores when saturated with aqueous solution; bioartificial organs |
| 04/21/2005 | US20050084503 Continuous cell line for the production of vaccines |
| 04/21/2005 | US20050084499 Comprises polypeptides for use in serodiagnosis and treatment of chlamydial sexually transmitted disease; vaccines |
| 04/21/2005 | US20050084497 Immunogens; replication-defective; antibodies; host cells; kits |
| 04/21/2005 | US20050084494 Dickkopf-1 (Dkk-1), a previously known polypeptide; treating an osteolytic lesion where the Dkk-1 antagonist inhibits Dkk-1 activity on the Wnt signaling pathway; multiple myeloma |
| 04/21/2005 | US20050084480 Recombinant replication-defective adenovirus serotypes 11, 25, 34, 35, 48 and 49 as gene delivery vehicles for gene therapy; reduced drug resistance, increased effectiveness of vaccination |
| 04/21/2005 | US20050084449 Antibodies against T cell immunoglobulin domain and mucin domain 1 (TIM-1) antigen and uses thereof |
| 04/21/2005 | CA2548787A1 Antibody composition specifically binding to ganglioside gm2 |
| 04/21/2005 | CA2544630A1 Method and material for enhanced tissue-biomaterial integration |
| 04/21/2005 | CA2542860A1 Fluorescence indicator utilizing fret |
| 04/21/2005 | CA2542130A1 Cell genomically modified to produce polypeptides with an altered glycosylation pattern |
| 04/21/2005 | CA2542125A1 Process for producing antibody composition by using rna inhibiting the function of .alpha.1,6-fucosyltransferase |
| 04/21/2005 | CA2542121A1 Genomically modified cell neutralized to serum-free system |
| 04/21/2005 | CA2542120A1 Methods of preparing and using stem cell compositions and kits comprising the same |
| 04/21/2005 | CA2542046A1 Fused protein composition |
| 04/21/2005 | CA2542042A1 Antibody composition specifically binding to il-5 receptor |
| 04/21/2005 | CA2542037A1 Composition of antibody capable of specifically binding ccr4 |
| 04/21/2005 | CA2542035A1 Process for producing antithrombin iii composition |
| 04/21/2005 | CA2541380A1 Use of cell lines to produce active therapeutic proteins |
| 04/21/2005 | CA2541317A1 Multi-layered polymerizing hydrogels for tissue regeneration |
| 04/21/2005 | CA2540165A1 Native immunoglobulin binding reagents and methods for making and using same |
| 04/21/2005 | CA2539681A1 Nucleic acid molecules encoding novel human low-voltage activated calcium channel proteins, designated - alpha 1i-1 and alpha 1i-2, encoded proteins and methods of use thereof |
| 04/21/2005 | CA2539346A1 Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders |
| 04/21/2005 | CA2538903A1 Isolated photoprotein mtclytin, and use thereof |
| 04/21/2005 | CA2535982A1 Uses of interferons with altered spatial structure |
| 04/20/2005 | EP1524320A1 Rapid determination and quantification of mycoplasma contamination using DNA chip technology |
| 04/20/2005 | EP1523990A1 Cellular vesicles denoted as 'exosomes', their preparation and use in the stimulation of an immune response |
| 04/20/2005 | EP1523564A1 Methods for inducing targeted stimulation of meiotic recombination and kits for performing said methods |
| 04/20/2005 | EP1523558A1 Production of peptides and proteins by accumulation in plant endoplasmic reticulum-derived protein bodies |
| 04/20/2005 | EP1523553A2 Multiply-substituted protease variants |
| 04/20/2005 | EP1523550A2 Immortalized colon epithelial cells and the use thereof |
| 04/20/2005 | EP1523549A2 Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury |
| 04/20/2005 | EP1523491A2 Maize clavata3-like polynucleotide sequences and methods of use |
| 04/20/2005 | EP1523323A2 Reagents and methods for smooth muscle therapies |
| 04/20/2005 | EP1523322A2 Novel proteins and nucleic acids encoding same |
| 04/20/2005 | EP1523308A2 Phenylthiocarbamide (ptc) taste receptor |
| 04/20/2005 | EP1226436B1 Universal fluorescent sensors |
| 04/20/2005 | EP1185649B1 The myostatin gene promoter and inhibition of activation thereof |
| 04/20/2005 | EP1141326B1 Human akt-3 |
| 04/20/2005 | EP1041890B1 Carbohydrate oxidase and use thereof in baking |
| 04/20/2005 | EP1009753B1 Hypoxia-regulated genes |
| 04/20/2005 | EP1002120B1 Chimeric adenoviral vectors |
| 04/20/2005 | EP0873398B1 A method for in vivo production of a mutant library in cells |
| 04/20/2005 | EP0871704B1 Transcriptional co-repressor that interacts with nuclear hormone receptors and uses therefor |
| 04/20/2005 | EP0835301B1 Monoclonal antibody directed against rat beta 2 integrin alpha d subunit and corresponding hybridoma |
| 04/20/2005 | EP0813604B1 Control of gene expression in plants by receptor mediated transactivation in the presence of a chemical ligand |
| 04/20/2005 | EP0805859B1 A chemokine receptor able to bind to mcp-1, mip-1 alpha and/or rantes. its uses |
| 04/20/2005 | EP0775213B1 Adenovirus comprising a gene coding for glutathion peroxidase |
| 04/20/2005 | EP0759995B1 Fusion glycoprotein from hcmv and hsv |
| 04/20/2005 | EP0700430B1 Methods for selectively stimulating proliferation of t cells |
| 04/20/2005 | CN1608129A Alkaline protease from bacillus sp. (DSM 14392) and washing and cleaning products comprising said alkaline protease |
| 04/20/2005 | CN1608025A Article handling system and method |
| 04/20/2005 | CN1607960A Glycoprotein compositions |
| 04/20/2005 | CN1607959A Human polypeptides causing or leading to the killing of cells including lymphoid tumor cells |
| 04/20/2005 | CN1607391A Method for predicating time of taking out ova for external fertilization |
| 04/20/2005 | CN1607249A Cotton laccase transgenic plant and its application |
| 04/20/2005 | CN1607247A Dendritic cell tumor vaccine and its preparation and use |
| 04/20/2005 | CN1607006A Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma |
| 04/20/2005 | CN1197968C Disulfide cross-linked glycoprotein hormone analogs, their preparation and use |
| 04/20/2005 | CN1197966C Modulators of TNF receptor associated factor (TRAF), their preparation and use |
| 04/20/2005 | CN1197960C Immortalized human kerationocyte cell line |
| 04/20/2005 | CN1197959C Ephedra crown-gall nodule cell ZHA-2 CGMCC NO.0521 and its inducing method |
| 04/20/2005 | CN1197876C Chimeric protein containing an intramolecular chaperone-like sequence and its application to insulin production |
| 04/20/2005 | CN1197624C Natural porous polymer beads, the preparation and application thereof |
| 04/20/2005 | CN1197618C Mutant cholera holotoxin as an adjuvant |
| 04/19/2005 | US6881833 Component in the hedgehog signalling pathway |
| 04/19/2005 | US6881832 Comprises nucleotide sequences coding signal sequences for transport of heterologous proteins into preferential cellular compartments |
| 04/19/2005 | US6881827 Molecular cloning of a 7TM receptor (AXOR34) and screening methods thereof |
| 04/19/2005 | US6881823 Comprises nucleotide sequences coding secreted polypeptides for diagnosing, preventing |
| 04/19/2005 | US6881747 Small molecules for inhibition of function and drug delivery to leukocytes |
| 04/19/2005 | US6881575 Using fluorescent activated cell sorting to separate and isolate cells comprising mutations in cell proliferation; anticarcinogenic agents; antiproliferative agents |
| 04/19/2005 | US6881574 Noninvasive detection of colorectal cancer and other gastrointestinal pathology |
| 04/19/2005 | US6881564 Enzymatic peptide comprising modified asparaginic residues for treatment of tumors, infection, liver and autoimmune disorders |
| 04/19/2005 | US6881559 Enzymatic polypeptide for use as amplification tool in genetic engineering |
| 04/19/2005 | US6881552 Human protease associated proteins |
| 04/19/2005 | US6881413 The invention relates to humanized biomaterial comprising a porous biocompatible composite material customized and implanted with monocyte derived cells preferably with macrophages. |
| 04/19/2005 | US6881411 Method of stimulating an immune response by administration of host organisms that express intimin alone or as a fusion protein with one or more other antigens |
| 04/19/2005 | US6881395 Ligand for use as tool in the treatment of tumors in humans |
| 04/19/2005 | CA2265252C Angiogenic factor and use thereof in treating cardiovascular disease |
| 04/19/2005 | CA2263713C Lyophilization of cultured human cells to preserve rna and dna |
| 04/19/2005 | CA2213223C Methods for maintaining sterility in plants |
| 04/19/2005 | CA2154447C In vitro maturation of oocytes with inhibin activin or inhibin/activin combinations |
| 04/19/2005 | CA2152477C Assessment of bone cell activity |
| 04/19/2005 | CA2059137C Enhancement of musculature in animals |
| 04/14/2005 | WO2005033702A1 Inspection chip, process for producing the same and method of inspection using the chip |
| 04/14/2005 | WO2005033320A1 Packaging cells for recombinant adenovirus |
| 04/14/2005 | WO2005033308A1 Schizophrenia-associated protein and gene coding for the same |
| 04/14/2005 | WO2005033305A1 PROCESS FOR PRODUCING INTERMEDIATE OF USEFUL ALKALOID BIOSYNTHESIS ACCORDING TO RNAi METHOD |
| 04/14/2005 | WO2005033302A1 Method of preparing hair papilla cell preparation, composition and method for regenerating hair follicle and animal having regenerated hair follicle |
| 04/14/2005 | WO2005033301A1 Cell activation method and cell production method and medicinal composition using the same |
| 04/14/2005 | WO2005033300A1 System and method for xenobiotic cell and tissue culture supported by surrogate avian vascular circulation |
| 04/14/2005 | WO2005033299A1 Method of repairing primate mammalian tissue |
| 04/14/2005 | WO2005033298A1 Method of inducing the differentiation of stem cells into myocardial cells |
| 04/14/2005 | WO2005033297A1 Compositions, methods and kits relating to reprogramming adult differentiated cells and production of embryonic stem cell-like cells |
| 04/14/2005 | WO2005033296A1 Methods of surface modification to enhance cell adhesion |
| 04/14/2005 | WO2005033295A1 Sperm cell separation by electrophoresis |